Jean‐Michel Hougardy

Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy

Jonathan Barratt, Richard Lafayette, Jens Kristensen et al. · Kidney International · 2022 · 215 citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +13

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Regulatory T Cells Depress Immune Responses to Protective Antigens in Active Tuberculosis

Jean‐Michel Hougardy, Sammy Place, Marc Hildebrand et al. · American Journal of Respiratory and Critical Care Medicine · 2007 · 185 citations

Life Sciences, Immunology, Infectious Diseases +17

Mental Health Outcomes in Healthcare Workers in COVID-19 and Non-COVID-19 Care Units: A Cross-Sectional Survey in Belgium

Julien Tiete, Magda Guatteri, Audrey Lachaux et al. · Frontiers in Psychology · 2021 · 117 citations · Full text

Health Professions, Mental Health Nursing, Behavioral Health +7

Heparin-Binding-Hemagglutinin-Induced IFN-γ Release as a Diagnostic Tool for Latent Tuberculosis

Jean‐Michel Hougardy, Kinda Schepers, Sammy Place et al. · PLoS ONE · 2007 · 111 citations · Full text

Public Health, Immunology, Infectious Diseases +17